What is CVE-2023-33364?

CVE-2023-33364 is a high-severity vulnerability in Supremainc Biostar_2, classified under OS Command Injection. CVSS score: 8.8/10. Published 2023-08-03.

How severe is CVE-2023-33364?

High severity. CVSS v3 base score is 8.8 out of 10.

RCE in Supremainc Biostar_2

CVE-2023-33364

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.015 (72.3th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

Affected products

Supremainc Biostar_2
N/a — versions n/a

Weakness classification (CWE)

CWE-78 — OS Command Injection

References

cve@mitre.org (Release Notes, Vendor Advisory)
cve@mitre.org (Third Party Advisory)

Frequently asked questions

What is CVE-2023-33364?: CVE-2023-33364 is a high-severity vulnerability in Supremainc Biostar_2, classified under OS Command Injection. CVSS score: 8.8/10. Published 2023-08-03.
How severe is CVE-2023-33364?: High severity. CVSS v3 base score is 8.8 out of 10.